AnaptysBio Inc (ANAB)

55.11 -0.54%

AnaptysBio Inc (ANAB) is currently trading at $55.11. This represents a loss of 0.54% from the previous session. With a market capitalization of $1.53B, ANAB is a key component of the Health Care sector. Investors looking to trade ANAB should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade ANAB commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, AnaptysBio Inc (ANAB) shows a bearish trend. Analysts are watching the 57.22 level closely.

Fundamentals
Mkt Cap1.53B
P/E Ratio0.0000
Volume258,495
Others Watching (By Market Cap)
CORT
Corcept Therape $36.22
-0.71% LGND
Ligand Pharmace $191.39
+1.26% ADMA
ADMA Biologics $15.68
+1.03% LEGN
Legend Biotech $19.72
+1.13% HIMS
Hims & Hers Hea $15.82
+2.33%
60-Day Technical Chart
Advanced Charting

Need more indicators for ANAB? Use the world's #1 platform.

Open ANAB on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $55
Metric ANAB
-0.54% 		BAC
+2.54% 		FITB
+2.70% 		TEM
-7.32%
Price $55.11 $51.69 $51.56 $53.71
Mkt Cap $1.53B $372.81B $46.40B $9.56B
- View → View → View →
Latest Headlines
FDA weighs drug for rare skin flares after 53% cleared in trial Stock Titan • Feb 25, 2026 Biotech Leader Eyes Spinoff Amid Massive Sales Surge Investor's Business Daily • Feb 3, 2026 Anaptys Announces Participation at Upcoming Investor Conferences GlobeNewswire • Feb 5, 2026 $ANAB stock is down 9% today. Here's what we see in our data. Quiver Quantitative • Sep 15, 2025 ANAB Stock Falls After Company Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal Stocktwits • Nov 21, 2025
● Gemini Agentic AI Analyst Insight for ANAB
Market Education
View All Articles →
External Research